Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 11061

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.43, p 0.243). This receipt's hash covers every field on it, plus the hash of receipt 11060, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 11061
    26 Oct 2026, 17:43 UTC

    FDFT1

    oligodendrocytes, braak

    predictionFDFT1 in oligodendrocytes tracks Braak Lewy-body stage

    registered0c83fe73b5563222

    discovery+0.43 p=0.243 n=9

    replication-0.43 p=0.249 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.43, p 0.243)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    5fe327a920bf0bc87d4a80df…
    follows 376aebe40a40…

Covered by the on-chain checkpoint of receipt 11075 (2026-10-26 17:59 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 11061: FDFT1 in oligodendrocytes, braak

power
full sample +0.07 (p 0.787, n 18), 95% CI -0.41 to +0.52. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.17 (p 0.498, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.22 (p 0.389, n 18). could be the mix.
skeptic
leave-one-out range -0.07 to +0.16, sign flips 2; without severely affected donors +0.07 (p 0.787, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for FDFT1 in oligodendrocytes.

case closed: nothing better to follow up.